The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes [PDF]
Diabetes & Metabolism Journal, 2014 BackgroundWe evaluated the effects of two dipeptidyl peptidase-4 (DPP-4) inhibitors, sitagliptin and vildagliptin, on metabolic parameters in patients with type 2 diabetes mellitus.MethodsA total of 170 type 2 diabetes patients treated with sitagliptin ...
Eun Yeong Choe +10 more
doaj +1 more source
Different behaviour of the N-terminal and C-terminal fragment of proatrial natriuretic factor in plasma of healthy subjects as well as of patients with cirrhosis [PDF]
, 1990 N-terminal (atrial natriuretic factor (ANF) 1-98) and C-terminal (ANF 99-126) fragments of proatrial natriuretic factor (NTA and CTA, respectively) were determined in plasma of healthy subjects adopting different postures and in patients with cirrhosis ...
Arendt, Rainer M. +5 more
core +1 more source
The Glycated Albumin to Glycated Hemoglobin Ratio Might Not Be Associated with Carotid Atherosclerosis in Patients with Type 1 Diabetes [PDF]
Diabetes & Metabolism Journal, 2014 BackgroundThe ratio of glycated albumin to glycated hemoglobin (GA/A1c) is known to be elevated in subjects with type 2 diabetes mellitus (T2DM) who had decreased insulin secretion.
Wonjin Kim +5 more
doaj +1 more source
Pharmacologic approaches against advanced glycation end products (ages) in diabetic cardiovascular disease [PDF]
, 2015 Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological complications in diabetic and non-diabetic patients.
Avtaar Singh, Sanjeet Singh +6 more
core +2 more sources
Postmortem diagnosis of diabetes mellitus and its complications. [PDF]
, 2015 Diabetes mellitus has become a major cause of death worldwide and diabetic ketoacidosis is the most common cause of death in children and adolescents with type 1 diabetes.
Palmiere, C.
core +3 more sources
Comprehensive overview of human serum albumin glycation in diabetes mellitus
World Journal of Diabetes, 2021 The presence of excess glucose in blood is regarded as a sweet hurt for patients with diabetes. Human serum albumin (HSA) is the most abundant protein in human plasma, which undergoes severe non-enzymatic glycation with glucose in patients with diabetes; this modifies the structure and function of HSA.
Qiu, Hong-Yan +6 more
openaire +2 more sources
A Carbon-Based Antifouling Nano-Biosensing Interface for Label-Free POCT of HbA1c
Biosensors, 2021 Electrochemical biosensing relies on electron transport on electrode surfaces. However, electrode inactivation and biofouling caused by a complex biological sample severely decrease the efficiency of electron transfer and the specificity of biosensing ...
Zhenhua Li +4 more
doaj +1 more source
Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus. [PDF]
PLoS ONE, 2017 BACKGROUND:Albumin glycation and subsequent formation of advanced glycation end products (AGEs) correlate with diabetes and associated complications.
Alok Raghav, Jamal Ahmad, Khursheed Alam
doaj +1 more source
Journal of Diabetes Investigation, 2020 Aims/Introduction To investigate the association of alternative glycemic measures – namely, serum glycated albumin (GA), hemoglobin A1c (HbA1c) and the GA : HbA1c ratio – with global brain and hippocampal atrophy in a general elderly Japanese population.
Tomoyuki Ohara +9 more
doaj +1 more source
Evaluation of the Role of HBA1c in Chronic Kidney Disease [PDF]
Journal of Clinical and Diagnostic Research, 2018 Introduction: Chronic Kidney Disease (CKD) refers to a group of heterogeneous disorders that results in gradual loss of structure and function of the kidneys.
Kommineni Sai Subramanyam +3 more
doaj +1 more source